Global Innovative Platforms GIPL
OTC GIPL
$0.50 +0.00 (+0.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

Global Innovative Platforms (GIPL) Net Equity Issued and Repurchased (2023 - 2026)

Updated

Global Innovative Platforms (GIPL) posted Net Equity Issued and Repurchased of $105,646 for fiscal Q3 2026 (quarter ended Jun 30, 2026), down 53.4% from $226,501 a year earlier.

Analysis

Global Innovative Platforms (GIPL) Net Equity Issued and Repurchased (2023 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Net Equity Issued and Repurchased at Global Innovative Platforms was $232,137.

  • The fiscal Q3 2026 figure stands as the lowest quarterly Net Equity Issued and Repurchased since fiscal Q3 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 43.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 6.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 9.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 47.70 Mn
10 Global Innovative Platforms 24.88 Mn 24.27 Mn - 105,646.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 105,646.00
Jun 30, 2025 226,501.00
Jun 30, 2024 -10.00
Jun 30, 2023 -100,000.00
API Access

Global Innovative Platforms Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=GIPL&period=max&api_key=YOUR_API_KEY